Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Systemic sclerosis
•
Neurology
How do you manage trigeminal sensory neuropathy in a patient with systemic sclerosis?
Related Questions
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
What would be your recommendation for treatment of worsening lung disease in a patient with long-standing scleroderma after long-term mycophenolate therapy which is no longer an option due to side effect/intolerance?
How would you approach a patient with anti-scl70 ab positive sine scleroderma complicated by ILD who also has seropositive RA with active arthritis?
What is your workup and treatment approach for cranial neuropathies in patients with lupus?
How would you manage a patient with diffuse Systemic Sclerosis who develops severe rapidly progressive calcinosis?
Are there situations in which you treat calcinosis cutis that is not symptomatic for the patient?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Would you consider altering immunosuppression in a patient with systemic sclerosis (already on systemic immunosuppression for interstitial lung disease) who has more recently been noted to have LV diastolic dysfunction with some reduction in EF in the absence of other worsening symptoms?
If a patient has progression of scleroderma-ILD on MMF alone, and you are planning to start tocilizumab, would you continue MMF at a lower dose to maintain skin softening?
